Transjugular intrahepatic portosystemic shunt for patients with cirrhosis and acute variceal bleeding:rescue or first-line therapy?

Han GuoHong; Qi XingShun; Fan DaiMing

Issue 3

Mar. 2011

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(3): 239-240+247

PDF( 1989 KB)

Transjugular intrahepatic portosystemic shunt for patients with cirrhosis and acute variceal bleeding:rescue or first-line therapy?

Published Date: 2011-03-20

Abstract

Abstract

In the current American Association for the Study of Liver Disease Practice Guidelines, the use of transjugular intrahepatic portosystemic shunt (TIPS) to control variceal bleeding has largely been recommended for patients who require rescue therapy because hemostasis has not been achieved.TIPS is extremely effective in controlling bleeding, nevertheless, mortality at 6 weeks among patients treated with rescue TIPS for uncontrolled index bleeding is very high.Recently, the results of a multi-center randomized controlled study that compared early TIPS with optimal medical therapy in patients at high risk for rebleeding who were either in Child-Pugh class B with active bleeding at endoscopy or in Child-Pugh class C showed the benefit of early TIPS.Therefore, the early use of TIPS with an e-PTFE-covered stent as first-line therapy rather than as rescue treatment if rebleeding occurs in high-risk patients with Child-Pugh B or C disease.
- portosystemic shunt,
- transjugular intrahepatic,
- esophageal and gastric varices,
- gastrointestinal hemorrhage,
- hypertension

FullText(HTML)

References(19)

References

[1]Garcia-Tsao G, Bosch J.Management of varices and variceal hemorrhage in cirrhosis[J].N Engl J Med, 2010, 362 (9) :823-832.

[2]Rossle M, Richter GM, Noldge G, et al.Performance of an intrahepatic portocaval shunt (PCS) using a catheter technique-a case report[J].Hepatology, 1988, 8:1348A.

[3]Papatheodoridis GV, Goulis J, Leandro G, et al.Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding:a meta-analysis[J].Hepatology, 1999, 30 (3) :612-622.

[4]Luca A, D'Amico G, La Galla R, et al.TIPS for prevention of recurrent bleeding in patients with cirrhosis:meta-analysis of randomized clinical trials[J].Radiology, 1999, 212 (2) :411-421.

[5]Burroughs AK, Vangeli M.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy:randomized trials for secondary prophylaxis of variceal bleeding:an updated meta-analysis[J].Scand J Gastroenterol, 2002, 37 (3) :249-252.

[6]Zheng M, Chen Y, Bai J, et al.Transjugular intrahepatic portosystemic shunt versus endscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients meta-analysis update[J].J Clin Gastroenterol, 2008, 42 (5) :507-516.

[7]Boyer TD, Haskal ZJ.The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension:update 2009[J].Hepatology, 2010, 51 (1) :306.

[8]Garcia-Tsao G, Sanyal AJ, Grace NG, et al.Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Hepatology, 2007, 46 (3) :922-938.

[9]Rossle M.TIPS:an update[J].Best Prac Res Clin Gastroenterol, 2004, 18 (1) :99-123.

[10]Riggio O, Ridola L, Lucidi S, et al.Emerging issue in the use of transjugular intrahepatic portosystemic shunt (TIPS) for the management of portal hypertension:time to update the guidelines?[J].Dig Liv Dis, 2010, 42 (7) :462-467.

[11]Afdhal NH, Curry MP.Early TIPS to improve survival in acute variceal bleeding[J].N Engl J Med, 2010, 362 (25) :2421-2422.

[12]Moitinho E, Escorsell A, Bandi J, et al.Prognostic value of early measurements of portal pressure in active variceal bleeding[J].Gastroenterology, 1999, 117 (3) :626-631.

[13]Moitinho E, Planas R, Baares R, et al.Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding[J].J Hepatol, 2001, 35 (6) :712-718.

[14]D'Amico G, De Franchis R.Upper digestive bleeding in cirrhosis.Post-therapeutic outcome and prognostic indictors[J].Hepatology, 2003, 38 (3) :599-612.

[15]Abraldes JG, Villanueva C, Baares R, et al.Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy[J].J Hepatol, 2008, 48 (2) :229-236.

[16]Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, et al.Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding[J].Hepatology, 2004, 40 (4) :793-801.

[17]García-Pagán JC, Caca K, Bureau C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].N Engl J Med, 2010, 362 (25) :2370-2379.

[18]Rossle M, Grandt D.Early Transjugular intrahepatic porto-systemic shunt in patients with cirrhosis and variceal bleeding[J].Hepatology, 2010, 52 (5) :1847-1849.

[19]Bureau C, Garcia-Pagan JC, Otal P, et al.Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS:results of a randomized study[J].Gastroenterology, 2004, 126 (2) :469-475.

Relative Articles

[1]	Mengying LIU, Weizhi LI, Peijie LI, Fuquan MA, Yuling CHEN, Huanhuan SUN, Tiantian GAO, Hui XUE. Comparison of endoscopic therapy and TIPS in prophylaxis and treatment of variceal bleeding in decompensated portal hypertension[J]. Journal of Clinical Hepatology, 2023, 39(7): 1529-1534. doi: 10.3969/j.issn.1001-5256.2023.07.003
[2]	Li XiaoLu, Ding HuiGuo, Ceng AJuan, Lu: XinYue, Li Lei. Clinical effect of terlipressin combined with somatostatin in treatment of esophagogastric variceal bleeding with liver cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(6): 1273-1277. doi: 10.3969/j.issn.1001-5256.2020.06.017
[3]	Lu Zheng, Han JingJing, Yu XiaoLi, Zhang WenHui, Chu JinDong, Ma XueMei, Jin Bo, Liu Bo, Wang YanLing, Han Jun, Wu Qin, Li HanWei. Clinical features of rebleeding after secondary prevention for esophagogastric variceal bleeding in cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2020, 36(8): 1747-1752. doi: 10.3969/j.issn.1001-5256.2020.08.014
[4]	Huang Shan, Zhou Hao, Chen XueLing, Yao Xin, Tang ShanHong, Yang GuoDong, Qin JianPing. Effect of transjugular intrahepatic portosystemic shunt on the liver and the heart[J]. Journal of Clinical Hepatology, 2020, 36(4): 904-907. doi: 10.3969/j.issn.1001-5256.2020.04.043
[5]	ZHANG Han, XIAO JiangQiang, ZHANG Ming, ZHANG Feng, ZHU GeYuZheng. Balloon-occluded retrograde transvenous obliteration for treating recurrent bleeding after transjugular intrahepatic portosystemic shunt: A report of 2 cases[J]. Journal of Clinical Hepatology, 2020, 36(12): 2798-2800. doi: 10.3969/j.issn.1001-5256.2020.12.031
[6]	Yao Xin, Zhou Hao, Tang ShanHong, Huang Shan, Chen XueLing, Qin JianPing. Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2020, 36(9): 1970-1974. doi: 10.3969/j.issn.1001-5256.2020.09.012
[7]	Zou SongLong, Xu Ying. Prognostic evaluation of transjugular intrahepatic portosystemic shunt in treatment of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2019, 35(1): 201-204. doi: 10.3969/j.issn.1001-5256.2019.01.044
[8]	Sun YaNan, Li Peng, Ding HuiGuo, Zhang ShiBin, Xiong Feng. Risk factors for early rebleeding after initial sclerotherapy for esophageal varices[J]. Journal of Clinical Hepatology, 2019, 35(1): 92-97. doi: 10.3969/j.issn.1001-5256.2019.01.017
[9]	The Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension (2019 edition)[J]. Journal of Clinical Hepatology, 2019, 35(12): 2694-2699. doi: 10.3969/j.issn.1001-5256.2019.12.010
[10]	Li Jing, Jiang Yong, Zhang Xu. Efficacy of transjugular intrahepatic portosystemic shunt versus endoscopic cyanoacrylate injection in treatment of gastric variceal bleeding: A meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(2): 349-353. doi: 10.3969/j.issn.1001-5256.2019.02.021
[11]	Zhou LinFeng, Wang WanSheng, Zhu XiaoLi, Li WanCi, Tang HaoHuan. Feasibility, safety, and clinical effect of establishing a green channel for the treatment of cirrhotic portal hypertension with esophagogastric variceal bleeding[J]. Journal of Clinical Hepatology, 2019, 35(5): 996-1001. doi: 10.3969/j.issn.1001-5256.2019.05.013
[12]	Ding ZhiFeng, Yin ShiWu. Application of Viatorr covered stent in transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2018, 34(5): 1107-1110. doi: 10.3969/j.issn.1001-5256.2018.05.039
[13]	Chen Min, Zhang Feng, Zhang Ming, Li ZhenLei, He QiBin, Mou ChengCheng, Zhong WenQi, Zhu GeYuZheng. Clinical effect of transjugular intrahepatic portosystemic shunt combined with tissue adhesive embolization in treatment of gastroesophageal variceal rebleeding in cirrhotic patients[J]. Journal of Clinical Hepatology, 2018, 34(6): 1209-1214. doi: 10.3969/j.issn.1001-5256.2018.06.016
[14]	Niu Meng, Sun Jun, Xu Ke, Zhong HongShan. Retrospects and prospects of transjugular intrahepatic portosystemic shunt in China[J]. Journal of Clinical Hepatology, 2016, 32(2): 230-233. doi: 10.3969/j.issn.1001-5256.2016.02.005
[15]	Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014
[16]	Tian XiangGuo, Zhang ChunQing. Therapeutic strategy for gastroesophageal variceal bleeding of portal hypertension[J]. Journal of Clinical Hepatology, 2015, 31(3): 354-356. doi: 10.3969/j.issn.1001-5256.2015.03.009
[17]	Zhou HongHua, Xiang XiaoXing, Zhang MiaoMiao. Diagnosis and treatment of primary bleeding from esophageal varices in cirrhotic patients from Yangzhou,China: an analysis of 80 cases[J]. Journal of Clinical Hepatology, 2015, 31(3): 370-373. doi: 10.3969/j.issn.1001-5256.2015.03.013
[18]	Yang Hua, Liu YunXia, Li Peng, Yang ShaoQi, Wang YuanZhen. Analysis of risk factors for early rebleeding from esophageal and gastric varices in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(6): 540-542. doi: 10.3969/j.issn.1001-5256.2014.06.015
[19]	Wu JiYuan, Zhang DongQin, Zhang HaiYue, Wang LuWen, Gong ZuoJiong. Efficacy and safety of transjugular intrahepatic portosystemic shunt versus endoscopic therapy for prevention of variceal rebleeding in patients with cirrhosis: a meta-analysis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1272-1278. doi: 10.3969/j.issn.1001-5256.2014.12.010
[20]	Zheng LuanLuan, Han GuoHong, Fan DaiMing. Role of transjugular intrahepatic portosystemic shunt in prevention and treatment of variceal bleeding in liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 687-690. doi: 10.3969/j.issn.1001-5256.2014.07.031

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (435) PDF downloads(413)

Transjugular intrahepatic portosystemic shunt for patients with cirrhosis and acute variceal bleeding:rescue or first-line therapy?

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Transjugular intrahepatic portosystemic shunt for patients with cirrhosis and acute variceal bleeding:rescue or first-line therapy?

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content